Search results for: 'Contract development and manufacturing'

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...

This report examines the expanding role of smart contracts in city services, beginning with a foundational overview of blockchain technology and smart contracts, including their core principles and applications across various industries. Anchored by Frost & Sullivan’s top three strategic imperatives, the report examines how these technologies are r...

The Middle East manufacturing sector is undergoing a structural transformation driven by decarbonization imperatives, energy transition, and the economic diversification agendas of the Gulf Cooperation Council (GCC) governments. Carbon intensity is emerging as a key competitive differentiator, particularly as the European Union (EU)'s Carbon Border...

The metals and manufacturing sector across the Middle East is undergoing a fundamental structural shift, driven by the convergence of decarbonization mandates, energy transition demand, industrial localization policies, and digital transformation imperatives. This study examines the evolving competitive landscape and identifies ten high-priority gr...

This Frost & Sullivan analysis examines the technological and industrial landscape of sustainable manufacturing for flexible electronics. It reviews the top 10 technologies and trends, assessing their relevance, maturity, and potential to enable environmentally responsible, high-efficiency production. It explores how these technologies can reduce m...

The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As monoclonal antibodies, bispecific antibodies, Fc-fus...

The increasing volatility of global supply chains is driving interest in microfactories and distributed manufacturing. Manufacturers aim to improve production flexibility, reduce reliance on lengthy logistics routes, and enhance resilience in times of disruption. Traditionally, manufacturing networks have been optimized for centralized production, ...

The Advanced Manufacturing Technology Opportunity Engine provides profiles of innovations related to a dexterous robotic hand with tactile sensing designed for sustained industrial operations, a compact high-degree-of-freedom robotic hand enabling seamless integration across humanoid platforms, and AI-driven robotic automation systems enhancing pal...